American BriVision Announces Issuance of a Full Clinical Study Report (CSR) for ABV-1504 for Major Depressive Disorder Phase II Study

    NEXT STORY
    Global Endoscope Market is Set to Reach USD 32.8 billion by 2024, Observing a CAGR of 7.5% during 2019–2024: VynZ Research
    PREV STORY
    Histology and Cytology Market To Reach USD 30,543.4 Million By 2026 | Reports And Data
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Athenex Announces Chinese FDA Allowance of Investigational New Drug Application of Oraxol to Begin Clinical Trials

    BUFFALO, N.Y., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    Cellectar Biosciences Enters into Strategic Collaboration with Onconova Therapeutics to Develop New Phospholipid Drug Conjugates

    MADISON, Wis., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused, ...

    author_avatar
    NASDAQ Market News

    Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results

    BERKELEY HEIGHTS, N.J., March 28, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) ...

    author_avatar
    NASDAQ Market News